TFS Capital’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-55,104
| Closed | -$606K | – | 563 |
|
|
2017
Q2 | $606K | Sell |
55,104
-40,328
| -42% | -$444K | 0.24% | 138 |
|
|
2017
Q1 | $935K | Sell |
95,432
-49,143
| -34% | -$481K | 0.3% | 107 |
|
|
2016
Q4 | $1.56M | Buy |
144,575
+19,985
| +16% | +$216K | 0.42% | 29 |
|
|
2016
Q3 | $1.28M | Buy |
124,590
+83,572
| +204% | +$857K | 0.31% | 115 |
|
|
2016
Q2 | $536K | Buy |
41,018
+1,580
| +4% | +$20.6K | 0.1% | 357 |
|
|
2016
Q1 | $434K | Sell |
39,438
-199,666
| -84% | -$2.2M | 0.06% | 494 |
|
|
2015
Q4 | $2.2M | Sell |
239,104
-84,311
| -26% | -$776K | 0.24% | 144 |
|
|
2015
Q3 | $2.25M | Buy |
323,415
+84,343
| +35% | +$585K | 0.22% | 131 |
|
|
2015
Q2 | $2.35M | Buy |
239,072
+122,013
| +104% | +$1.2M | 0.23% | 114 |
|
|
2015
Q1 | $1.04M | Sell |
117,059
-20,756
| -15% | -$184K | 0.1% | 335 |
|
|
2014
Q4 | $1.21M | Sell |
137,815
-70,985
| -34% | -$622K | 0.12% | 276 |
|
|
2014
Q3 | $1.44M | Buy |
+208,800
| New | +$1.44M | 0.12% | 258 |
|
|
2014
Q1 | – | Sell |
-42,157
| Closed | -$212K | – | 1735 |
|
|
2013
Q4 | $212K | Sell |
42,157
-203,524
| -83% | -$1.02M | 0.01% | 1267 |
|
|
2013
Q3 | $1.25M | Sell |
245,681
-324,821
| -57% | -$1.65M | 0.06% | 505 |
|
|
2013
Q2 | $2.83M | Buy |
+570,502
| New | +$2.83M | 0.12% | 242 |
|